Barclays raised the firm’s price target on Universal Health (UHS) to $257 from $249 and keeps an Overweight rating on the shares post the Q1 report. The company delivered a solid beat despite lagging behavioral volumes impacted by weather and leap year, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS: